ST. LOUIS—Fleishman-Hillard and clinical trial development company PRA International have entered into a strategic alliance to offer an integrated approach to supporting clinical trial work. PRA provides clinical research services to the pharmaceutical and biotechnology industries, while Fleishman’s clinical trials division provides international patient recruitment services for clinical trials.
With a global staff of more than 2,500, PRA International helps create cost-effective, time-efficient strategies to conduct any aspect of a clinical development trial or program. According to PRA International’s president and chief executive officer, “The strategic partnership between PRA and Fleishman-Hillard will bring our customers a dynamic range of options that can be tailored to meet their patient recruitment needs.”
“Fleishman-Hillard and PRA are natural partners, given our firm’s unique approach to patient recruitment and PRA’s commitment to quality, performance, and building repeat business in the CRO sector,” says FH chairman John Graham. “The global reach of this alliance can bring a full range of communications services to clients anywhere in the world.”